Free Trial

Afya (NASDAQ:AFYA) Trading Up 4% - What's Next?

Afya logo with Consumer Discretionary background

Key Points

  • Afya Limited's stock price increased by 4%, trading at $15.52, despite a 67% decline in trading volume compared to its average daily volume.
  • Analysts have mixed ratings for Afya, with a consensus rating of "Hold" and an average price target of $17.50, while Morgan Stanley and UBS Group issued positive price targets of $17.50 and $19.50, respectively.
  • Hedge funds collectively hold 88.02% of Afya's stock, with significant equity increases by firms such as Doma Perpetual Capital Management and Renaissance Technologies in the latest quarters.
  • Need better tools to track Afya? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Afya Limited (NASDAQ:AFYA - Get Free Report) was up 4% on Thursday . The stock traded as high as $15.53 and last traded at $15.52. Approximately 36,893 shares traded hands during trading, a decline of 67% from the average daily volume of 112,097 shares. The stock had previously closed at $14.92.

Analyst Ratings Changes

Several equities research analysts have weighed in on AFYA shares. Morgan Stanley set a $17.50 price target on Afya and gave the stock an "overweight" rating in a report on Wednesday, August 6th. UBS Group restated a "neutral" rating and set a $19.50 price target (up previously from $17.50) on shares of Afya in a report on Thursday, June 12th. Wall Street Zen downgraded Afya from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Finally, Citigroup upgraded Afya from a "sell" rating to a "neutral" rating and cut their price target for the stock from $16.00 to $14.00 in a report on Tuesday, July 29th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $17.50.

Get Our Latest Stock Analysis on Afya

Afya Stock Up 2.2%

The business has a 50 day moving average of $16.21 and a 200-day moving average of $17.24. The stock has a market cap of $1.43 billion, a PE ratio of 11.55, a P/E/G ratio of 0.52 and a beta of 0.53. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.41.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in AFYA. Doma Perpetual Capital Management LLC grew its stake in Afya by 92.3% during the 4th quarter. Doma Perpetual Capital Management LLC now owns 567,109 shares of the company's stock worth $9,006,000 after buying an additional 272,200 shares during the last quarter. Carrera Capital Advisors purchased a new position in Afya during the 2nd quarter worth approximately $1,750,000. Wellington Management Group LLP purchased a new position in Afya during the 4th quarter worth approximately $829,000. Renaissance Technologies LLC grew its stake in Afya by 14.0% during the 4th quarter. Renaissance Technologies LLC now owns 412,000 shares of the company's stock worth $6,543,000 after buying an additional 50,700 shares during the last quarter. Finally, Jump Financial LLC purchased a new position in Afya during the 2nd quarter worth approximately $731,000. Hedge funds and other institutional investors own 88.02% of the company's stock.

Afya Company Profile

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines